Cinnamon L Hardee

571 total citations
10 papers, 438 citations indexed

About

Cinnamon L Hardee is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Cinnamon L Hardee has authored 10 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Cinnamon L Hardee's work include Virus-based gene therapy research (8 papers), RNA Interference and Gene Delivery (5 papers) and CAR-T cell therapy research (4 papers). Cinnamon L Hardee is often cited by papers focused on Virus-based gene therapy research (8 papers), RNA Interference and Gene Delivery (5 papers) and CAR-T cell therapy research (4 papers). Cinnamon L Hardee collaborates with scholars based in United States. Cinnamon L Hardee's co-authors include Lynn Zechiedrich, Benjamin D. Hornstein, Donald B. Kohn, Francesca Giannoni, Roger P. Hollis, David Baltimore, James S. Economou, Antoni Ribas, Laurence J.N. Cooper and David Elashoff and has published in prestigious journals such as Blood, The Journal of Immunology and Molecular Therapy.

In The Last Decade

Cinnamon L Hardee

10 papers receiving 427 citations

Peers

Countries citing papers authored by Cinnamon L Hardee

Since Specialization

Citations

This map shows the geographic impact of Cinnamon L Hardee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cinnamon L Hardee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cinnamon L Hardee more than expected).

Fields of papers citing papers by Cinnamon L Hardee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cinnamon L Hardee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cinnamon L Hardee. The network helps show where Cinnamon L Hardee may publish in the future.

Co-authorship network of co-authors of Cinnamon L Hardee

This figure shows the co-authorship network connecting the top 25 collaborators of Cinnamon L Hardee. A scholar is included among the top collaborators of Cinnamon L Hardee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cinnamon L Hardee. Cinnamon L Hardee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Improving therapeutic potential of non-viral minimized DNA vectors 2020 ·Cell and Gene Therapy Insights ·(unknown), Cinnamon L Hardee, Jonathan M. Fogg, (unknown), (unknown), Lynn Zechiedrich	11
2	Dosing and Re-Administration of Lentiviral Vector for In Vivo Gene Therapy in Rhesus Monkeys and ADA-Deficient Mice 2019 ·Molecular Therapy — Methods & Clinical Development ·Denise A. Carbonaro-Sarracino, Alice F. Tarantal, C. Chang I. Lee, Michael L. Kaufman, Stephen Wandro, (unknown), (unknown), (unknown), (unknown), (unknown), Cinnamon L Hardee, Xiaoyan Wang, Donald B. Kohn	15
3	Advances in Non-Viral DNA Vectors for Gene Therapy 2017 ·Genes ·Cinnamon L Hardee, (unknown), Benjamin D. Hornstein, Lynn Zechiedrich	262
4	Effects of Vector Backbone and Pseudotype on Lentiviral Vector-mediated Gene Transfer: Studies in Infant ADA-Deficient Mice and Rhesus Monkeys 2014 ·Molecular Therapy ·(unknown), Alice F. Tarantal, (unknown), (unknown), (unknown), Xiaoyan Wang, Cinnamon L Hardee, Sabine Geiger, Christoph Kahl, Donald B. Kohn	7
5	Modification of Hematopoietic Stem/Progenitor Cells with CD19-Specific Chimeric Antigen Receptors as a Novel Approach for Cancer Immunotherapy 2013 ·Human Gene Therapy ·Satiro De Oliveira, Christine E. Ryan, Francesca Giannoni, Cinnamon L Hardee, (unknown), (unknown), (unknown), (unknown), Andy Tu, Tristan Grogan, David Elashoff, Laurence J.N. Cooper, Roger P. Hollis, Donald B. Kohn	51
6	Allelic Exclusion and Peripheral Reconstitution by TCR Transgenic T Cells Arising From Transduced Human Hematopoietic Stem/Progenitor Cells 2013 ·Molecular Therapy ·Francesca Giannoni, Cinnamon L Hardee, (unknown), Eric H. Gschweng, Shantha Senadheera, Michael L. Kaufman, (unknown), Ingrid Bahner, Vivian H. Gersuk, Xiaoyan Wang, David W. Gjertson, David Baltimore, Owen N. Witte, James S. Economou, Antoni Ribas, Donald B. Kohn	48
7	Gene Transfer to Hematopoietic Stem/Progenitor Cells As a Novel Approach for Immunotherapy Against B-Lineage Malignancies: In Vivo Xenograft Model, 2011 ·Blood ·Satiro De Oliveira, Francesca Giannoni, Cinnamon L Hardee, (unknown), Laurence J.N. Cooper, Donald B. Kohn	1
8	Regulated Expansion of Human Pancreatic β-Cells 2010 ·Molecular Therapy ·(unknown), Jean Park, Tamás Alexy, Vahagn C. Nikolian, Shundi Ge, Kit L. Shaw, Shantha Senadheera, Cinnamon L Hardee, Dianne C. Skelton, Roger P. Hollis, Gay M. Crooks, Donald B. Kohn	1
9	Lentiviral vectors with amplified β cell-specific gene expression 2009 ·Gene Therapy ·Kit L. Shaw, (unknown), Shundi Ge, Cinnamon L Hardee, Dianne C. Skelton, Roger P. Hollis, Gay M. Crooks, Donald B. Kohn	6
10	CD4+CD25− T Cells Transduced to Express MHC Class I-Restricted Epitope-Specific TCR Synthesize Th1 Cytokines and Exhibit MHC Class I-Restricted Cytolytic Effector Function in a Human Melanoma Model 2008 ·The Journal of Immunology ·Arvind Chhabra, Lili Yang, Pin Wang, Begoña Comı́n-Anduix, Raja Das, Nitya G. Chakraborty, (unknown), Shikhar Mehrotra, Haiguang Yang, Cinnamon L Hardee, Roger P. Hollis, David I. Dorsky, Richard C. Koya, Donald B. Kohn, Antoni Ribas, James S. Economou, David Baltimore, Bijay Mukherji	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact